🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rachna T. Shroff

University of Arizona

ORCID: 0000-0003-0066-2672

Also affiliated with Arizona Oncology, University of Arizona Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.165Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multi-omic characterization of early-onset esophagogastric cancer

npj Precision Oncology(2025)10.1038/s41698-025-01030-4
Top 70%
0.165DataRank
Top 70%2 citations

Sachin Kumar Deshmukh, Sharon Wu, Joanne Xiu, Sung Joo Jang, Jimyung Park +6 more

Papers

Driven by 21 papers — median percentile 30. Top paper: “Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors”.

Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors

Nature Medicine(2021)10.1038/s41591-021-01542-z
N/A
6.7DataRank · unranked
224 citations

Pavani Chalasani, Ran Wei, Daniel J. Pennington, Grace Quirk, Marta V. Schoenle +17 more

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Journal of Clinical Oncology(2024)10.1200/jco-24-01383
N/A
1.1DataRank · unranked
51 citations

Gentry Teng King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff +17 more

Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma

Cancers(2020)10.3390/cancers12123816
N/A
0.701DataRank · unranked
106 citations

Jayati Chakrabarti, Joanne Lundy, Daniel Croagh, Pritha Adhikary, Scott S. Richards +13 more

O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Annals of Oncology(2023)10.1016/j.annonc.2023.04.017
N/A
0.624DataRank · unranked
5 citations

I. Bazin, Do‐Youn Oh, O. Zubkov, V. Breder, Li‐Yuan Bai +16 more

Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older

Pancreatology(2020)10.1016/j.pan.2020.01.005
N/A
0.561DataRank · unranked
41 citations

Jane E. Rogers, Kenneth R. Hess, Robert A. Wolff, Gauri R. Varadhachary, Milind Javle +7 more

Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates

Nature Communications(2025)10.1038/s41467-025-63718-2
N/A
0.557DataRank · unranked
40 citations

Brandon G. Smaglo, Krishnan K. Mahadevan, Michelle L. Kirtley, Kathleen M. McAndrews, Mayela Carolina Mendt +19 more

A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma

Annals of Oncology(2024)10.1016/j.annonc.2024.12.011
N/A
0.538DataRank · unranked
35 citations

Daniel DiToro, Francesco Facchinetti, E Martin, P. Peng, Islam Baiev +50 more

Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3724
N/A
0.483DataRank · unranked
24 citations

Andrew Elliott, Matthew H. Bailey, David Stone, Kajsa E. Affolter, Heloisa P. Soares +9 more

Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer

JCO Precision Oncology(2023)10.1200/po.23.00152
N/A
0.464DataRank · unranked
21 citations

Yasmine Baca, Jennifer R. Ribeiro, Phillip Walker, Gregory C. Wilson, Prateek Gulhati +14 more

Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0388
N/A
0.241DataRank · unranked
4 citations

Madhulika Eluri, Ernest T. Hawk, Akram Shalaby, Elif Karatas, Ahmed Shalaby +13 more

Multi-omic characterization of early-onset esophagogastric cancer

npj Precision Oncology(2025)10.1038/s41698-025-01030-4
Top 70%
0.165DataRank
Top 70%2 citations

Sachin Kumar Deshmukh, Sharon Wu, Joanne Xiu, Sung Joo Jang, Jimyung Park +6 more

Multi-omic characterization reveals a distinct molecular landscape in young-onset pancreatic cancer

medRxiv(2023)10.1101/2023.03.28.23287894
N/A
0.104DataRank · unranked
1 citations

Yasmine Baca, Jennifer R. Ribeiro, Phillip Walker, Gregory C. Wilson, Prateek Gulhati +14 more

The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.150
N/A
0DataRank · unranked
143 citations

Francesco Facchinetti, Daniel DiToro, Islam Baiev, Umair Majeed, Sylvia A. Reyes +24 more

The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad121
N/A
0DataRank · unranked
9 citations

Barbara Burtness, May Cho, Jaydira Del Rivero, Deborah B. Doroshow, Kathryn Hitchcock +12 more

Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad046
N/A
0DataRank · unranked
28 citations

Leontios Pappas, Islam Baiev, Jordan R. Maurer, Andrea Grace Bocobo, Karen Zhang +25 more

Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy

medRxiv(2021)10.1101/2021.05.13.21257129
N/A
0DataRank · unranked
37 citations

Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V. Schoenle +17 more

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin

UNC Libraries(2020)10.17615/kke1-de47
N/A
0DataRank · unranked
0 citations

Thomas LaFramboise, Michael S. Lee, Cathy Eng, David R. Fogelman, Stanley R. Hamilton +14 more

A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1552
N/A
0DataRank · unranked
12 citations

Shane A. Olwill, Erika Hamilton, Anthony W. Tolcher, Paula R. Pohlmann, Stephen V. Liu +16 more

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH -Mutant Molecular Profiles

UNC Libraries(2020)10.17615/7ms0-1a34
N/A
0DataRank · unranked
0 citations

Umadevi Veluvolu, Mario Berríos, David E. Kleiner, Donghui Tan, Johanna Gardner +95 more

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

The Oncologist(2025)10.1093/oncolo/oyaf007
N/A
0DataRank · unranked
7 citations

Edik M. Blais, John Davelaar, Matthew Ebia, Angela Minasyan, Nima Nikravesh +13 more

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.lba490
N/A
0DataRank · unranked
99 citations

Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin +15 more